Posted by
The Benefits of TMS & TBS with MagVita

The Benefits of TMS & TBS with MagVita

TMS (Transcranial Magnetic Stimulation) is an FDA-cleared, non-invasive, non-drug therapy for patients with Major Depressive Disorders.  In our practice we use a highly advanced MagVita TMS therapy system that possesses unique attributes relative to other available products.  The market for TMS-based therapy has been growing, and the medical devices and accessories that are used to […]

Posted by
Suicide Rates Increasing Across US, CDC Report Finds

Suicide Rates Increasing Across US, CDC Report Finds

The CBS Evening News (6/7, story 3, 3:05, Glor) reported, “The CDC put out an alarming report today on suicide. Nearly 45,000 Americans took their lives in 2016. That is more than car accidents or opioid overdoses.” On ABC World News Tonight (6/7, story 7, 1:40, Muir), ABC News correspondent Gio Benitez said that “the CDC is reporting that […]

Posted by

Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial

Background Treatment-resistant major depressive disorder is common; repetitive transcranial magnetic stimulation (rTMS) by use of high-frequency (10 Hz) left-side dorsolateral prefrontal cortex stimulation is an evidence-based treatment for this disorder. Intermittent theta burst stimulation (iTBS) is a newer form of rTMS that can be delivered in 3 min, versus 37·5 min for a standard 10 […]

Posted by
Intranasal Esketamine Succeeds in Depression Trial

Intranasal Esketamine Succeeds in Depression Trial

4-point cut in MADRS scores versus placebo after 4 weeks by Kristen Monaco, Staff Writer, MedPage TodayMay 09, 2018 NEW YORK CITY — Intranasal esketamine paired with an oral antidepressant improved symptoms of treatment-resistant depression, researchers reported here. When compared to intranasal placebo plus an antidepressant, two phase III studies found twice-weekly flexibly-dosed intranasal esketamine added to […]

Posted by
Ketamine: A depression drug that researchers have called ‘the most important discovery in half a century’ just got a big lift

Ketamine: A depression drug that researchers have called ‘the most important discovery in half a century’ just got a big lift

Ketamine, which has been called “the most important discovery in half a century,” just got a step closer to becoming the first new depression drug in 35 years. Johnson & Johnson, one of the pharmaceutical companies pursuing the drug’s fast-acting antidepressant qualities, presented some promising new research on Saturday that could raise the drug’s profile as a potential treatment for […]

Posted by
A New Study on Theta Burst Stimulation Out of Canada

A New Study on Theta Burst Stimulation Out of Canada

Three-minute magnetic brain stimulation treatments can reduce depression symptoms: study A three-minute treatment involving magnetic stimulation of the brain works just as well as the standard form of such therapy for people with hard-to-treat depression, a new study has found. The success of the intermittent theta-burst stimulation (iTBS) therapy could greatly increase the number of […]

Posted by
Music as Medicine: Ancient Wisdom, Modern Science

Music as Medicine: Ancient Wisdom, Modern Science

Healing Then and Now With Music Therapeutic uses of music date back to antiquity. Healing shrines in Ancient Greece housed both hymn specialists and physicians.[2] Native American tribes chanted, danced, and played drums to heal illness. And early Christian priests used hymns to ease pain in the sick. Today, scientific studies confirm what the ancients […]

Posted by
Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study

Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study

An interesting and unusual approach to migraines in a difficult population: Credits: Samantha L. Irwin MSc, MB BCH BAO, FRCPC, William Qubty MD, I. Elaine Allen PhD, Irene Patniyot MD, Peter J. Goadsby MD, PhD, Amy A. Gelfand MAS, MD First published: 12 March 2018 [Buy the Full Research Article HERE] Abstract Objective To assess the feasibility, […]